María Teresa Calderón-González
Research Subjects
María Teresa Calderón-González has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Juan Antonio Portela-Camino
Department of Optometry, Begira Ophthalmologic Clinic, Bilbao, Spain
2 shared publications - Santiago Martín
Department of Construction and Manufacturing Engineering, University of Oviedo, Asturias, Spain
2 shared publications - Irene Sanchez
Departamento de Física Teórica, Atómica y Óptica, Universidad de Valladolid, Valladolid, Spain
1 shared publication - Juan de la Cruz Cardona
Department of Optics, Faculty of Science, University of Granada, Campus Fuente Nueva, Edificio Mecenas, s/n 18071, Granada, Spain
1 shared publication - Maria Pérez-Benito
Servicio de Oftalmología, Hospital de Mérida, 06800 Mérida, Badajoz, Spain
1 shared publication - Raquel Amigo-Gamero
Servicio de Oftalmología, Hospital de Mérida, 06800 Mérida, Badajoz, Spain
1 shared publication
Latest Publications
- Open Access
- 27 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (5) , 1817
Combined Occlusion Therapy and Home-Based Perceptual Learning in Children with Persistent Amblyopia: A Longitudinal Case Series
Objectives: Persistent amblyopia often shows limited response to occlusion therapy once visual acuity improvement plateaus. This study evaluated the efficacy of a two-phase protocol combining occlusion therapy and home-based perceptual learning (PL) in children with persistent amblyopia, including those with congenital pathology. Methods: This longitudinal case series included 40 patients (mean age 9.4 ± 3.4 years). Phase I consisted of occlusion therapy until best-corrected visual acuity (BCVA) plateaued. Phase II combined continued occlusion with home-based PL training until BCVA in amblyopic eye reached 0.00 logMAR or treatment was discontinued. BCVA and stereoacuity (TNO test) were assessed at baseline, after Phase I, after Phase II when applicable, and at a prospective evaluation visit. Treatment success was defined as a gain of ≥2 logMAR lines or a final BCVA ≤0.10 logMAR. Patients were stratified according to cumulative training exposure (p < 0.01). After Phase II, BCVA further improved to 0.13 ± 0.16 logMAR (p < 0.01). Stereoacuity showed a modest but significant improvement, from 928 ± 505 to 748 ± 558 arcsec (p = 0.01). Treatment success was achieved in 72% of patients completing ≥10 h of perceptual learning compared with 40% in those completing <10 h (RR = 1.94, 95% CI 1.01–3.73). Patients with non-pathological amblyopia achieved greater final BCVA than those with congenital pathology. Conclusions: The combination of occlusion therapy and home-based PL was associated with further improvement in visual acuity and modest gains in stereoacuity in children with persistent amblyopia. Greater cumulative training exposure was associated with higher treatment success, supporting PL as a clinically valuable adjunct to standard amblyopia management.
- 27 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (5) , 1817
Open AccessCombined Occlusion Therapy and Home-Based Perceptual Learning in Children with Persistent Amblyopia: A Longitudinal Case Series
Objectives: Persistent amblyopia often shows limited response to occlusion therapy once visual acuity improvement plateaus. This study evaluated the efficacy of a two-phase protocol combining occlusion therapy and home-based perceptual learning (PL) in children with persistent amblyopia, including those with congenital pathology. Methods: This longitudinal case series included 40 patients (mean age 9.4 ± 3.4 years). Phase I consisted of occlusion therapy until best-corrected visual acuity (BCVA) plateaued. Phase II combined continued occlusion with home-based PL training until BCVA in amblyopic eye reached 0.00 logMAR or treatment was discontinued. BCVA and stereoacuity (TNO test) were assessed at baseline, after Phase I, after Phase II when applicable, and at a prospective evaluation visit. Treatment success was defined as a gain of ≥2 logMAR lines or a final BCVA ≤0.10 logMAR. Patients were stratified according to cumulative training exposure (p < 0.01). After Phase II, BCVA further improved to 0.13 ± 0.16 logMAR (p < 0.01). Stereoacuity showed a modest but significant improvement, from 928 ± 505 to 748 ± 558 arcsec (p = 0.01). Treatment success was achieved in 72% of patients completing ≥10 h of perceptual learning compared with 40% in those completing <10 h (RR = 1.94, 95% CI 1.01–3.73). Patients with non-pathological amblyopia achieved greater final BCVA than those with congenital pathology. Conclusions: The combination of occlusion therapy and home-based PL was associated with further improvement in visual acuity and modest gains in stereoacuity in children with persistent amblyopia. Greater cumulative training exposure was associated with higher treatment success, supporting PL as a clinically valuable adjunct to standard amblyopia management.
- Open Access
- 19 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 6
Effects of Perceptual Learning Through Binocular Virtual Reality Exercises on Low Stereopsis
Objectives: To evaluate the feasibility and efficacy of a brief, scaffolded virtual reality (VR)-based perceptual-learning protocol to improve stereovision in adults without measurable baseline global stereopsis. Methods: Prospective interventional pilot study with a normal-vision reference group. Fourteen adults were enrolled; nine with nil global stereoacuity formed the intervention group and five with normal binocular vision served as controls. Intervention participants completed 8–10 VR sessions (~30 min each over two weeks) using a disparity-driven depth-matching task with individualized thresholds, virtual prism compensation, and interocular contrast balancing. Primary outcomes were changes in clinical stereoacuity (local and global) and Binocular Function (BF). Secondary outcomes included positive fusional vergence (PFV), binocular imbalance (inter-ocular contrast ratio), and in-game depth discrimination error (arcseconds). Results: Global stereoacuity improved with four of nine participants who initially showed no measurable global stereopsis achieving measurable thresholds after training (post: 861.11 ± 537.08 arcsec, IQR = 800.00; p = 0.06). Local stereoacuity improved near (pre: 616.67 ± 532.68 arcsec, IQR = 1100.00; post: 361.67 ± 537.11, IQR = 200.00; p = 0.03) and at a distance (pre: 715.11 ± 573.54 arcsec, IQR = 1114.00; post: 437.11 ± 510.41, IQR = 405.00; p = 0.03). BF score improved from 4.33 ± 0.50 (IQR = 1.00) to 3.51 ± 1.14 (IQR = 1.30) (p = 0.03). PFV break at distance increased (pre: 17.83 ± 17.53Δ, IQR = 23.50; post: 24.50 ± 17.12Δ, IQR = 28.50; p = 0.04), and the binocular imbalance showed a nonsignificant trend towards improvement (p = 0.09). In-game depth error decreased from 752.11 ± 384.50 arcsec (IQR = 553.00) to 221.78 ± 79.12 (IQR = 105.00) (p < 0.01). Control participants achieved a mean depth error of 43.00 ± 10.30 arcsec after three sessions. Conclusions: A short-dose, individualized VR protocol yielded gains in stereoacuity and binocular function in adults with severe stereodeficiency, with transfer from in-game learning to standard clinical measures. While the sample size was limited, the approach proved feasible and was well tolerated, showing encouraging efficiency versus prior high-dose regimens.
- 19 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 6
Open AccessEffects of Perceptual Learning Through Binocular Virtual Reality Exercises on Low Stereopsis
Objectives: To evaluate the feasibility and efficacy of a brief, scaffolded virtual reality (VR)-based perceptual-learning protocol to improve stereovision in adults without measurable baseline global stereopsis. Methods: Prospective interventional pilot study with a normal-vision reference group. Fourteen adults were enrolled; nine with nil global stereoacuity formed the intervention group and five with normal binocular vision served as controls. Intervention participants completed 8–10 VR sessions (~30 min each over two weeks) using a disparity-driven depth-matching task with individualized thresholds, virtual prism compensation, and interocular contrast balancing. Primary outcomes were changes in clinical stereoacuity (local and global) and Binocular Function (BF). Secondary outcomes included positive fusional vergence (PFV), binocular imbalance (inter-ocular contrast ratio), and in-game depth discrimination error (arcseconds). Results: Global stereoacuity improved with four of nine participants who initially showed no measurable global stereopsis achieving measurable thresholds after training (post: 861.11 ± 537.08 arcsec, IQR = 800.00; p = 0.06). Local stereoacuity improved near (pre: 616.67 ± 532.68 arcsec, IQR = 1100.00; post: 361.67 ± 537.11, IQR = 200.00; p = 0.03) and at a distance (pre: 715.11 ± 573.54 arcsec, IQR = 1114.00; post: 437.11 ± 510.41, IQR = 405.00; p = 0.03). BF score improved from 4.33 ± 0.50 (IQR = 1.00) to 3.51 ± 1.14 (IQR = 1.30) (p = 0.03). PFV break at distance increased (pre: 17.83 ± 17.53Δ, IQR = 23.50; post: 24.50 ± 17.12Δ, IQR = 28.50; p = 0.04), and the binocular imbalance showed a nonsignificant trend towards improvement (p = 0.09). In-game depth error decreased from 752.11 ± 384.50 arcsec (IQR = 553.00) to 221.78 ± 79.12 (IQR = 105.00) (p < 0.01). Control participants achieved a mean depth error of 43.00 ± 10.30 arcsec after three sessions. Conclusions: A short-dose, individualized VR protocol yielded gains in stereoacuity and binocular function in adults with severe stereodeficiency, with transfer from in-game learning to standard clinical measures. While the sample size was limited, the approach proved feasible and was well tolerated, showing encouraging efficiency versus prior high-dose regimens.